| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,602 |
Mesoblast Maintains Momentum with FDA
|
12 Jun 2025 10:14AM |
$1.820 |
$2.010 |
risen by
10.44%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
SHOCK DOCTOR MANUFACTURING AGREEMENT
|
12 Jun 2025 10:09AM |
$0.019 |
$0.010 |
fallen by
47.37%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited entered into a manufacturing agreement with Shock Doctor, a division of United Sports Brands.
- The agreement focuses on the manufacturing of smart mouthguard devices using HitIQ’s technology.
- Shock Doctor’s global manufacturing and distribution capabilities will be leveraged.
- The agreement is expected to enhance production scale, quality, and international market reach.
- HitIQ aims to access key international markets through Shock Doctor’s established infrastructure.
- The partnership is strategically significant for scaling HitIQ’s business operations.
- The agreement details manufacturing terms, distribution plans, and expected business benefits.
- Improved efficiencies and cost-effectiveness in manufacturing are anticipated.
- The agreement supports HitIQ’s mission to expand its presence in the sports technology sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wide Open Agriculture Ltd (WOA) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
High Purity Lupin Oil Extracted from Initial Trials
|
12 Jun 2025 10:06AM |
$0.019 |
$0.009 |
fallen by
52.63%
|
|
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Application for quotation of securities - TMG
|
12 Jun 2025 10:05AM |
$0.082 |
$0.120 |
risen by
46.34%
|
|
| NetLinkz Limited (NET) ORDINARY FULLY PAID |
Information Technology |
- |
Half Yearly Report and Accounts
|
12 Jun 2025 10:01AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$21 |
EVR Completes Acquisition of Los Lirios Antimony Mine
|
12 Jun 2025 9:59AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- EV Resources Limited completed the acquisition of the Los Lirios Antimony Mine in Sonora, Mexico.
- The acquisition supports EV Resources' strategy to focus on critical minerals, particularly antimony.
- Antimony is identified as a critical mineral for industrial, technological, and defense applications.
- The transaction structure and due diligence process have been completed.
- Ongoing operational plans for Los Lirios aim to enhance production and resource development.
- The acquisition is expected to strengthen the company’s supply chain for critical minerals.
- Global demand for antimony is rising, increasing the relevance of such resource assets.
- The Los Lirios mine acquisition complements EV Resources' existing asset portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Touch Ventures Limited (TVL) ORDINARY FULLY PAID |
Financials |
$44 |
Net Tangible Asset Backing - May 2025
|
12 Jun 2025 9:57AM |
$0.069 |
$0.062 |
fallen by
10.14%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$268,156 |
Issue of AUD 1.5 Billion worth of Subordinated Securities
|
12 Jun 2025 9:54AM |
$181.400 |
$160.240 |
fallen by
11.66%
|
|
| Mayur Resources Limited (MRL) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
- |
Pause in Trading
|
12 Jun 2025 9:54AM |
$0.285 |
$0.300 |
risen by
5.26%
|
|
MRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Mayur Resources Limited requested a trading halt on its securities.
- The trading halt is pending an announcement about a capital raising.
- ASX granted the trading halt effective from the start of trading on 5 June 2024.
- The halt will last until the earlier of 7 June 2024 or the release of the announcement.
- The halt is to ensure the market is fully informed and to maintain an orderly market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$472 |
NAV 31 May 2025
|
12 Jun 2025 9:54AM |
$1.130 |
$1.770 |
risen by
56.64%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$108 |
Successful Phase 2 clinical trial of ISLA-101
|
12 Jun 2025 9:53AM |
$0.200 |
$0.365 |
risen by
82.50%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited completed Phase 2 PEACH trial for ISLA-101.
- The study met key efficacy and safety endpoints for dengue fever prevention and treatment.
- ISLA-101 demonstrated a favorable safety profile in the tested population.
- Results support continued development and progression to later-stage clinical studies.
- The company is engaging with regulatory authorities for the advancement of ISLA-101.
- ISLA-101 offers a potential solution for mosquito-borne viral diseases, including dengue.
- Island Pharmaceuticals will explore partnerships and additional funding opportunities.
- There is a significant unmet need for dengue therapeutics globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$320 |
NTA at 06.06.25 Pre-tax 140.41 Post-tax 135.27
|
12 Jun 2025 9:52AM |
$1.200 |
$1.240 |
risen by
3.33%
|
|
| Saunders International Limited (SND) ORDINARY FULLY PAID |
Industrials |
$147 |
Final Director's Interest Notice
|
12 Jun 2025 9:52AM |
$0.765 |
$1.050 |
risen by
37.25%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$22 |
Dalaroo to Acquire Advanced Gold Project - Updated
|
12 Jun 2025 9:51AM |
$0.042 |
$0.062 |
risen by
47.62%
|
|
| Katana Capital Limited (KAT) ORDINARY FULLY PAID |
Financials |
$43 |
Update - Notification of buy-back - KAT
|
12 Jun 2025 9:49AM |
$1.210 |
$1.350 |
risen by
11.57%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$90,509 |
Dividend/Distribution - MQGPD
|
12 Jun 2025 9:49AM |
$217.060 |
$237.470 |
risen by
9.40%
|
|
| MPR Australia Limited (MPR) ORDINARY FULLY PAID |
Financials |
$2 |
MPOWER TO SELL RENEWABLE ENERGY PLATFORM
|
12 Jun 2025 9:48AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
MPR - Price-sensitive ASX Announcement
Full Release
Key Points
- MPower Group Limited to sell its renewable energy platform to TagEnergy.
- The sale includes assets related to the development of renewable energy projects and a portfolio of Battery Energy Storage Systems (BESS).
- Transaction valued at AUD 20 million on a debt-free, cash-free basis.
- Proceeds from the sale will strengthen MPower's balance sheet.
- MPower will refocus efforts on its engineering, procurement, and construction (EPC) business.
- The transaction is subject to shareholder approval and customary conditions.
- MPower expects the sale to provide strategic and operational benefits.
- The deal is anticipated to position MPower for future growth in the energy sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (Hedged) (JPHQ) |
Financials |
$12 |
Distribution Tax Estimates
|
12 Jun 2025 9:48AM |
$54.980 |
$60.560 |
risen by
10.15%
|
|
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$8 |
EVE Completes Nextract Acquisition
|
12 Jun 2025 9:47AM |
$0.040 |
$0.023 |
fallen by
42.50%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited has completed the acquisition of Nextract Pty Ltd.
- The acquisition will enhance EVE's capacity in plant extraction and health product formulation.
- EVE expects to broaden its product portfolio and enter new markets with Nextract's capabilities.
- Integration of Nextract is set to drive growth and open up new commercial opportunities for EVE.
- The acquisition aligns with EVE's strategic objectives to become a leading player in the health and wellness sector.
- Management anticipates synergies from the acquisition to benefit shareholders and customers.
- Completion of the acquisition was announced on 28 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clara Resources Australia Limited (C7A) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
12 Jun 2025 9:46AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
C7A - Price-sensitive ASX Announcement
Full Release
Key Points
- Clara Resources Australia Limited (ASX: C7A) requested a trading halt on 4 June 2024.
- The trading halt is due to a pending announcement related to a capital raising.
- The halt will remain until the announcement is made or trading resumes on 6 June 2024.
- The company is taking this action to ensure an orderly market and appropriate information dissemination.
- Previously, the company was known as Australian Pacific Coal Limited (ASX: AQC).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AGL Energy Limited (AGL) ORDINARY FULLY PAID |
Utilities |
$5,779 |
Response to media speculation
|
12 Jun 2025 9:46AM |
$10.240 |
$8.590 |
fallen by
16.11%
|
|
AGL - Price-sensitive ASX Announcement
Full Release
Key Points
- AGL Energy Limited responds to media speculation about its operations.
- The company reviews all options to support its long-term strategy.
- No certainty that any specific transaction or option will be pursued.
- AGL is committed to continuous disclosure and will update the market as required.
- The response aims to clarify AGL’s position and obligations amid speculation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$85 |
AnteoBind Order Received and Life Sciences Update
|
12 Jun 2025 9:43AM |
$0.009 |
$0.026 |
risen by
188.89%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- AnteoTech Limited received a notable order for AnteoBind from ADO.
- This order strengthens AnteoTech’s commercial relationship with ADO and validates its surface coating technology.
- AnteoBind is gaining traction in the life sciences sector, particularly in immunoassay development and diagnostics.
- The company is pursuing strategic partnerships and collaborations to increase adoption of AnteoBind.
- AnteoTech is focused on expanding its commercial pipeline and increasing its global presence in the life sciences market.
- Updates include advancing business development activities and targeting key market segments.
- The announcement highlights the importance of the ADO order as a potential catalyst for further market penetration.
- AnteoTech continues to invest in its proprietary technologies and build relationships with new and existing customers.
- The company remains committed to innovation and commercial growth in the life sciences sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$135 |
Trading Halt
|
12 Jun 2025 9:43AM |
$0.059 |
$0.053 |
fallen by
10.17%
|
|
RNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Renascor Resources Limited (RNU) requested a trading halt to be applied to its securities.
- The trading halt was requested pending an announcement regarding a proposed capital raising.
- The halt was requested to last until the earlier of the commencement of normal trading on 17 June 2024 or when the announcement regarding the capital raising is made.
- The request was submitted in accordance with Listing Rule 17.1 of the ASX.
- The trading halt aims to ensure an orderly market in the company's securities while information about the capital raising is being prepared for release.
- The company will keep the market informed and will release the announcement as soon as possible.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Finder Energy Holdings Limited (FDR) ORDINARY FULLY PAID |
Energy |
$184 |
Trading Halt
|
12 Jun 2025 9:42AM |
$0.065 |
$0.340 |
risen by
423.08%
|
|
FDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Finder Energy Holdings Limited (ASX: FDR) requested a trading halt on its securities effective immediately.
- The trading halt was requested pending the release of an announcement regarding a capital raising.
- Finder Energy intends to make an announcement to the market concerning the capital raising as soon as possible.
- The company anticipates that the trading halt will remain in place until either the announcement is made or the commencement of normal trading on Thursday, 13 June 2024, whichever occurs first.
- Finder Energy is taking this step to ensure that the market is fully informed and to avoid trading on an uninformed basis.
- The request for a trading halt was submitted to the ASX by Finder Energy's Company Secretary.
- The document confirms compliance with ASX Listing Rule requirements for trading halts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$5 |
Second Seaweed Sale Under Sales Cooperation Agreement
|
12 Jun 2025 9:42AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd's subsidiary BP8 completed its second commercial seaweed sale.
- The sale involved a 40-ton shipment to a customer in China.
- This transaction is under a Sales Cooperation Agreement.
- The seaweed was sourced through BP8's established local partnerships in Indonesia.
- The sale demonstrates progress in BP8's commercialisation strategy.
- Further shipments and revenue growth are anticipated.
- The announcement reinforces BP8's role in the growing seaweed supply chain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
